Public Health Sciences, The University of Texas at El Paso, El Paso, TX, United States; South Texas Veterans Health Care System Audie L. Murphy Memorial Veterans Hospital Division 7400 Merton Minter Boulevard San Antonio, TX 78229; College of Health Sciences Research, Evaluation, and Academic Center on Health Disparities (CHS REACHED).
Department of Psychology, University of Wisconsin-Madison, Madison, WI, United States; Division of Geriatrics, Department of Medicine, The School of Medicine and Public Health (SMPH), University of Wisconsin-Madison, Madison, WI, United States; Department of Psychiatry, SMPH, UW-Madison, Madison, WI, USA; Geriatrics and Gerontology, Dept. of Medicine, SMPH, UW-Madison, Madison, WI, USA.
J Affect Disord. 2024 Nov 1;364:274-278. doi: 10.1016/j.jad.2024.08.063. Epub 2024 Aug 13.
Depression among older adults is a pressing public health concern, necessitating accurate assessment tools. The Geriatric Depression Scale (GDS) offers a brief and efficient means of screening depressive symptoms, yet its performance across ethno-racial groups remains understudied. This study aimed to compare the ability of various brief forms of the GDS to detect depressive symptoms and to assess potential ethno-racial differences in symptom endorsement among White, Black/African-American, and American Indian/Alaska Native older adults.
Data were obtained from the Wisconsin Alzheimer's Disease Research Center (ADRC) clinical cohort, comprising 555 cognitively healthy individuals at risk for dementia. We used participants' baseline data for this cross-sectional analysis. Depressive symptoms were assessed using multiple brief forms of the GDS, derived from a systematic review and meta-analysis. We examined internal consistency and correlations with global Clinical Dementia Rating (CDR) scores. We conducted Kruskal-Wallis tests and post hoc pairwise comparisons to assess ethno-racial group differences in symptom endorsement.
Descriptive statistics revealed a predominance of female and White participants, with notable representation from Black and American Indian/Alaska Native groups. All GDS versions demonstrated moderate to high internal consistency. Significant positive correlations were observed between GDS scores and global CDR scores. Ethno-racial group differences in depressive symptom endorsement were evident, with Black participants consistently reporting higher levels of symptoms across most GDS versions. However, American Indian/Alaska Native participants endorsed significantly fewer symptoms than Black participants in one GDS version.
The study highlights the importance of considering ethno-racial differences in depressive symptomatology when assessing older adults. While the GDS demonstrates overall reliability, variations in symptom endorsement across different ethno-racial groups underscore the need for culturally sensitive assessment tools and interventions. Future research should further explore these group differences and develop tailored approaches to depression screening and treatment in diverse older adult populations.
老年人的抑郁是一个紧迫的公共卫生问题,需要准确的评估工具。老年抑郁量表(GDS)提供了一种简短而有效的筛选抑郁症状的方法,但它在不同种族群体中的表现仍有待研究。本研究旨在比较不同简短形式的 GDS 检测抑郁症状的能力,并评估白种人、黑种人/非裔美国人和美洲印第安人/阿拉斯加原住民老年人中症状表达的潜在种族差异。
数据来自威斯康星州阿尔茨海默病研究中心(ADRC)临床队列,包括 555 名认知健康、有痴呆风险的个体。我们使用参与者的基线数据进行这项横断面分析。使用来自系统评价和荟萃分析的 GDS 的多种简短形式评估抑郁症状。我们检查了内部一致性和与全球临床痴呆评分(CDR)的相关性。我们进行了 Kruskal-Wallis 检验和事后两两比较,以评估症状表达的种族差异。
描述性统计显示,参与者主要为女性和白人,黑人及美洲印第安人/阿拉斯加原住民群体的代表性也很显著。所有 GDS 版本均表现出中等至高的内部一致性。GDS 评分与全球 CDR 评分之间存在显著正相关。在抑郁症状表达方面存在种族差异,黑人参与者在大多数 GDS 版本中报告的症状水平较高。然而,在一个 GDS 版本中,美洲印第安人/阿拉斯加原住民参与者的症状表达明显少于黑人参与者。
本研究强调了在评估老年人时考虑抑郁症状种族差异的重要性。虽然 GDS 具有总体可靠性,但不同种族群体之间症状表达的差异突出表明需要使用文化敏感的评估工具和干预措施。未来的研究应进一步探讨这些群体差异,并为不同的老年人群体开发有针对性的抑郁筛查和治疗方法。